Showing 4031-4040 of 5314 results for "".
- FDA Approves Valchlor Gel for the Treatment of Stage IA and IB Mycosis Fungoides-Type CTCLhttps://practicaldermatology.com/news/20130826-fda_approves_valchlor_gel_for_the_treatment_of_stage_ia_and_ib_mycosis_fungoides-type_ctcl/2459475/
- Acne-Specific Dermatology Platform Site Goes Livehttps://practicaldermatology.com/news/20130801-acne-specific_dermatology_platform_site_goes_live/2459485/
- AMA Foundation Awards Research Grants To Study Issues Affecting Women In Medicinehttps://practicaldermatology.com/news/20130521-ama_foundation_awards_research_grants_to_study_issues_affecting_women_in_medicine/2459535/In 1850, the first medical institution in the world established to train women in medicine and offer opportunities of an MD opened their doors in Philadelphia. For those women, it was a chance to enter the medical world that routinely shut them out. While women today don't face such a task, importan
- Onset Dermatologics Unveils Anti-Itch Gel for Eczemahttps://practicaldermatology.com/news/20130515-onset_unveils_anti-itch_gel_for_eczema/2459544/A new product for itching associated with eczema is now available from Onset Dermatologics. Aurstat® Anti-Itch Hydrogel is engineered to soothe itching, burning, and pain of atopic dermatitis and various dermatoses, according to the company. The patented hydrogel formulation is alcohol free, fragran
- Nuvo and Galderma Win FDA Approval for Topical Peelhttps://practicaldermatology.com/news/20121022-nuvo_and_galderma_win_fda_approval_for_topical_peel/2459699/Nuvo Research announced that the FDA has approved its Pliaglis product, a topical anesthetic cream designed to minimize pain during aesthetic dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. The approval
- Physicians Report Health IT Growing But Systems Laghttps://practicaldermatology.com/news/20120921-physicians_report_health_it_growing_but_systems_lag/2459732/A new Optum Institute/Harris Interactive national survey provides insights into US consumers' willingness to view their medical records and engage with care providers online. The survey was conducted online within the United States among 1,000 US physicians, 2,870 US adults, and 400 US hospital exec
- Healthcare Spending Growth Expected to Remain Lowhttps://practicaldermatology.com/news/20120603-healthcare_spending_growth_expected_to_remain_low/2459793/
- Leading Melanoma Groups Unveil New Campaign Aimed at Menhttps://practicaldermatology.com/news/20120515-leading_melanoma_groups_unveil_new_campaign_aimed_at_men/2459800/
- Rademikibart Shows High Long-Term Efficacy in Atopic Dermatitishttps://practicaldermatology.com/news/rademikibart-shows-high-long-term-efficacy-in-atopic-dermatitis/2486495/Rademikibart, a next-generation anti–IL-4 receptor alpha monoclonal antibody, demonstrated robust and sustained efficacy in moderate-to-severe atopic dermatitis (AD) through 52 weeks, according to Phase 3 RADIANT-AD data presented by Cheng Zhou, MD, at the American Academy of Dermatology (AAD) 20
- Nemolizumab Shows Efficacy in Pediatric Atopic Dermatitishttps://practicaldermatology.com/news/nemolizumab-shows-efficacy-in-pediatric-atopic-dermatitis/2486457/Nemolizumab, an IL-31 receptor alpha (IL-31Rα) antagonist, demonstrated favorable pharmacokinetics, sustained efficacy, and a consistent safety profile in children aged 2 to 11 years with moderate-to-severe atopic dermatitis (AD), according to Phase 2 data presented by Linda Stein Gold, MD, at th